Kentucky 2022 Regular Session

Kentucky Senate Bill SB56

Introduced
1/6/22  
Refer
1/6/22  
Refer
1/10/22  
Report Pass
1/12/22  
Engrossed
1/20/22  
Refer
1/20/22  
Refer
3/9/22  
Report Pass
3/17/22  
Enrolled
3/30/22  
Enrolled
3/30/22  
Chaptered
4/8/22  

Caption

AN ACT relating to opioid antagonists designed to reverse the effects of an opioid overdose.

Impact

The implications of SB56 are significant; it modifies existing laws pertaining to the dispensing of naloxone and expands the pool of individuals—such as emergency responders and school personnel—who can administer the medication during overdoses. This creates a framework for local schools to respond effectively to overdose situations, thereby potentially saving lives in communities affected by the opioid crisis. Clinics, pharmacies, and community organizations that provide health services are also positioned to play a larger role in harm reduction strategies.

Summary

SB56 is an act aimed at addressing the epidemic of opioid overdoses through several measures that promote the availability and administration of opioid antagonists, particularly naloxone. The bill establishes the Kentucky Opioid Abatement Advisory Commission, which is responsible for overseeing the disbursement of funds intended for opioid-related projects. This includes support for clinical protocols, public education, and professional training focused on preventing and responding to opioid overdoses. A key element of the legisation is to facilitate easier access to naloxone by allowing schools and other institutions to keep the medication on hand and ensuring training for personnel in its administration.

Sentiment

Sentiment around SB56 appears to be largely supportive, especially among public health advocates who view the measure as a crucial step in combating the opioid crisis. Supporters argue that the bill empowers local communities, increases access to life-saving medications, and lowers barriers to effective emergency responses. However, there may be some concerns regarding the implementation of education and training programs and the adequacy of resources provided to ensure effective responses to overdoes in multiple settings, which is a point of contention among healthcare professionals.

Contention

Notable points of contention include concerns about the funding and resources for the new initiatives proposed by the bill. Some critics voice skepticism regarding the ability of local entities to manage and implement the expanded responsibilities effectively. There are also worries about the potential for misuse or inadequate training in administering naloxone, despite the efforts made to enhance educational components within the bill. Balancing accessibility with the need for proper oversight and training remains a significant debate point.

Companion Bills

No companion bills found.

Previously Filed As

KY HB547

AN ACT relating to opioid antagonists.

KY HB431

AN ACT relating to opioid antagonists.

KY HB4783

Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

KY SB2378

Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

KY HB1293

Drug Overdose Education & Opioid Antagonists in Schools

KY SB2855

Relating To Opioid Antagonists.

KY HB1767

Relating To Opioid Antagonists.

KY HB310

Relating To Opioid Antagonists.

KY HB310

Relating To Opioid Antagonists.

KY HB1399

Relating To Opioid Antagonists.

Similar Bills

WI AB925

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

AZ HB2944

Inpatient treatment days; computation; exclusion

CA AB1879

Substance use: treatment or residential data reporting.

WI SB904

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

CA AB2538

Medi-Cal: hospice providers: forms.

AZ SB1244

court-ordered treatment; continuation

IA HF518

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)

IA HF326

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)